Submit Your Feeds

Business News • PR NewsWire • Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

TARRYTOWN, N.Y. and PARIS, Aug. 25, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31,...

View More : http://www.prnewswire.com/news-releases/regeneron-and-sanofi-to-present-results-from-four-phase-3-alirocumab-trials-in-h...
Releted News by prnewswire
Highest Honour in Corporate Governance for Shiv Nadar
Shiv Nadar recebe a mais alta distinção em governança corporativa
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
Höchste Ehren in Sachen Unternehmensführung für Shiv Nadar
Xait, the Leader in Oil and Gas Collaborative Authoring Solutions, at ONS 2014
Home Sitemap Contact Us
© businessNewsNewsNews.com